NDSI
GSK icon

Newman Dignan & Sheerar Inc’s GSK GSK Stock Holding History

Newman Dignan & Sheerar Inc’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-4,026
Closed -$231K – 153
2014
Q3 		$231K Sell
4,026
-684
-15% -$41.9K 0.17% 129
2014
Q2 		$315 Buy
4,710
+128
+3% +$8.66K 0.18% 113
2014
Q1 		$306K Buy
4,582
+382
+9% +$25.8K 0.22% 110
2013
Q4 		$280 Buy
+4,200
New +$272K 0.01% 125

Other funds holding GSK

LTI
Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Newman Dignan & Sheerar Inc's GSK Position: Q4 2014 in Review

Newman Dignan & Sheerar Inc sold out of GSK (GSK) in Q4 2014, closing a stake of 4,026 shares — an estimated $231K sold.

Newman Dignan & Sheerar Inc first reported a position in GSK in Q4 2013 and held it in 4 quarters. The position peaked at $306K in Q1 2014. 729 funds tracked by Wall St. Rank hold GSK as of Q4 2014.

  • Newman Dignan & Sheerar Inc reported no remaining GSK position as of Q4 2014 after selling out during the quarter.
  • Newman Dignan & Sheerar Inc sold 4,026 GSK shares in Q4 2014, an estimated $231K.
  • Newman Dignan & Sheerar Inc first reported a position in GSK in Q4 2013 and held it in 4 quarters.
  • Newman Dignan & Sheerar Inc's GSK position peaked at $306K in Q1 2014.
  • 729 funds tracked by Wall St. Rank held GSK as of Q4 2014.

Based on Newman Dignan & Sheerar Inc's 13F filing for Q4 2014, filed 28 Jan 2015.